LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma-Reference-Cited by-同舟云学术

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma

Published:2022-12-26 Issue:1 Volume:37 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Wang Shan¹,Chen Zhaoxin¹,Lv Hongwei¹,wang Cong¹,Wei Huamin²,Yu Jing¹^ORCID

Affiliation:

1. Cancer Center, Beijing Friendship Hospital Capital Medical University Beijing China

2. Department of Traditional Chinese Medicine, Beijing Friendship Hospital Capital Medical University Beijing China

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24824

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Adjuvant chemotherapy for resectable non‐small‐cell lung cancer: where is it going?;Le Chevalier T;Med Oncol,2010

3. Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis

4. Biomarker Studies Abound for Early Detection of Lung Cancer

5. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway;Respiratory Research;2023-10-25